|
1
|
Epstein MA, Achong BG and Barr YM: Virus
particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet.
1:702–703. 1964. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Young LS and Rickinson AB: Epstein-Barr
virus: 40 years on. Nat Rev Cancer. 4:757–768. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Burke AP, Yen TS, Shekitka KM and Sobin
LH: Lymphoepithelial carcinoma of the stomach with Epstein-Barr
virus demonstrated by polymerase chain reaction. Mod Pathol.
3:377–380. 1990.PubMed/NCBI
|
|
4
|
Shibata D, Tokunaga M, Uemura Y, Sato E,
Tanaka S and Weiss LM: Association of Epstein-Barr virus with
undifferentiated gastric carcinomas with intense lymphoid
infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol.
139:469–474. 1991.PubMed/NCBI
|
|
5
|
Shibata D and Weiss LM: Epstein-Barr
virus-associated gastric adenocarcinoma. Am J Pathol. 140:769–774.
1992.PubMed/NCBI
|
|
6
|
Fukayama M, Hayashi Y, Iwasaki Y, et al:
Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr
virus infection of the stomach. Lab Invest. 71:73–81.
1994.PubMed/NCBI
|
|
7
|
Marshall BJ and Warren JR: Unidentified
curved bacilli in the stomach of patients with gastritis and peptic
ulceration. Lancet. 1:1311–1315. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nomura A, Stemmermann GN, Chyou PH, Kato
I, Perez-Perez GI and Blaser MJ: Helicobacter pylori infection and
gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med.
325:1132–1136. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Parsonnet J, Friedman GD, Vandersteen DP,
et al: Helicobacter pylori infection and the risk of gastric
carcinoma. N Engl J Med. 325:1127–1131. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fukayama M and Ushiku T: Epstein-Barr
virus-associated gastric carcinoma. Pathol Res Pract. 207:529–537.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen JN, He D, Tang F and Shao CK:
Epstein-Barr virus-associated gastric carcinoma: a newly defined
entity. J Clin Gastroenterol. 46:262–271. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murphy G, Pfeiffer R, Camargo MC and
Rabkin CS: Meta-analysis shows that prevalence of Epstein-Barr
virus-positive gastric cancer differs based on sex and anatomic
location. Gastroenterology. 137:824–833. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Camargo MC, Kim WH, Chiaravalli AM, et al:
Improved survival of gastric cancer with tumour Epstein-Barr virus
positivity: an international pooled analysis. Gut. 63:236–243.
2014.
|
|
14
|
Boyle P and Levin B: Stomach Cancer. IARC
Press; Lyon: 2008
|
|
15
|
Camargo MC, Murphy G, Koriyama C, et al:
Determinants of Epstein-Barr virus-positive gastric cancer: an
international pooled analysis. Br J Cancer. 105:38–43. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee JH, Kim SH, Han SH, An JS, Lee ES and
Kim YS: Clinicopathological and molecular characteristics of
Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J
Gastroenterol Hepatol. 24:354–365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Truong CD, Feng W, Li W, et al:
Characteristics of Epstein-Barr virus-associated gastric cancer: a
study of 235 cases at a comprehensive cancer center in USA. J Exp
Clin Cancer Res. 28:142009. View Article : Google Scholar
|
|
18
|
Chen JN, Jiang Y, Li HG, et al:
Epstein-Barr virus genome polymorphisms of Epstein-Barr
virus-associated gastric carcinoma in gastric remnant carcinoma in
Guangzhou, southern China, an endemic area of nasopharyngeal
carcinoma. Virus Res. 160:191–199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Koriyama C, Akiba S, Minakami Y and Eizuru
Y: Environmental factors related to Epstein-Barr virus-associated
gastric cancer in Japan. J Exp Clin Cancer Res. 24:547–553.
2005.
|
|
20
|
Camargo MC, Koriyama C, Matsuo K, et al:
Case-case comparison of smoking and alcohol risk associations with
Epstein-Barr virus-positive gastric cancer. Int J Cancer.
134:948–953. 2014. View Article : Google Scholar :
|
|
21
|
van Beek J, zur Hausen A, Klein Kranenbarg
E, et al: EBV-positive gastric adenocarcinomas: a distinct
clinicopathologic entity with a low frequency of lymph node
involvement. J Clin Oncol. 22:664–670. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tokunaga M and Land CE: Epstein-Barr virus
involvement in gastric cancer: biomarker for lymph node metastasis.
Cancer Epidemiol Biomarkers Prev. 7:449–450. 1998.PubMed/NCBI
|
|
23
|
Matsunou H, Konishi F, Hori H, et al:
Characteristics of Epstein-Barr virus-associated gastric carcinoma
with lymphoid stroma in Japan. Cancer. 77:1998–2004. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Song HJ, Srivastava A, Lee J, et al: Host
inflammatory response predicts survival of patients with
Epstein-Barr virus-associated gastric carcinoma. Gastroenterology.
139:84–92.e82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Koriyama C, Akiba S, Itoh T, et al:
Prognostic significance of Epstein-Barr virus involvement in
gastric carcinoma in Japan. Int J Mol Med. 10:635–639.
2002.PubMed/NCBI
|
|
26
|
Kijima Y, Ishigami S, Hokita S, et al: The
comparison of the prognosis between Epstein-Barr virus
(EBV)-positive gastric carcinomas and EBV-negative ones. Cancer
Lett. 200:33–40. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tokunaga M, Land CE, Uemura Y, Tokudome T,
Tanaka S and Sato E: Epstein-Barr virus in gastric carcinoma. Am J
Pathol. 143:1250–1254. 1993.PubMed/NCBI
|
|
28
|
Chang MS, Lee HS, Kim HS, et al:
Epstein-Barr virus and microsatellite instability in gastric
carcinogenesis. J Pathol. 199:447–452. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kaizaki Y, Hosokawa O, Sakurai S and
Fukayama M: Epstein-Barr virus-associated gastric carcinoma in the
remnant stomach: de novo and metachronous gastric remnant
carcinoma. J Gastroenterol. 40:570–577. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee JY, Kim KM, Min BH, Lee JH, Rhee PL
and Kim JJ: Epstein-Barr virus-associated lymphoepithelioma-like
early gastric carcinomas and endoscopic submucosal dissection: case
series. World J Gastroenterol. 20:1365–1370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nakamura S, Ueki T, Yao T, Ueyama T and
Tsuneyoshi M: Epstein-Barr virus in gastric carcinoma with lymphoid
stroma. Special reference to its detection by the polymerase chain
reaction and in situ hybridization in 99 tumors, including a
morphologic analysis. Cancer. 73:2239–2249. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Watanabe H, Enjoji M and Imai T: Gastric
carcinoma with lymphoid stroma. Its morphologic characteristics and
prognostic correlations. Cancer. 38:232–243. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lauren P: The two histological main types
of gastric carcinoma: diffuse and so-called intestinal-type
carcinoma. An attempt at a histoclinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965.
|
|
34
|
Song HJ and Kim KM: Pathology of
epstein-barr virus-associated gastric carcinoma and its
relationship to prognosis. Gut Liver. 5:143–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shinozaki A, Ushiku T, Morikawa T, et al:
Epstein-Barr virus-associated gastric carcinoma: a distinct
carcinoma of gastric phenotype by claudin expression profiling. J
Histochem Cytochem. 57:775–785. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
van Beek J, zur Hausen A, Snel SN, et al:
Morphological evidence of an activated cytotoxic T-cell infiltrate
in EBV-positive gastric carcinoma preventing lymph node metastases.
Am J Surg Pathol. 30:59–65. 2006. View Article : Google Scholar
|
|
37
|
Kuzushima K, Nakamura S, Nakamura T, et
al: Increased frequency of antigen-specific CD8+
cytotoxic T lymphocytes infiltrating an Epstein-Barr
virus-associated gastric carcinoma. J Clin Invest. 104:163–171.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shinozaki A, Ushiku T and Fukayama M:
Prominent Mott cell proliferation in Epstein-Barr virus-associated
gastric carcinoma. Hum Pathol. 41:134–138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ushiku T, Shinozaki A, Uozaki H, et al:
Gastric carcinoma with osteoclast-like giant cells.
Lymphoepithelioma-like carcinoma with Epstein-Barr virus infection
is the predominant type. Pathol Int. 60:551–558. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Choi MG, Jeong JY, Kim KM, et al: Clinical
significance of gastritis cystica profunda and its association with
Epstein-Barr virus in gastric cancer. Cancer. 118:5227–5233. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tsao SW, Tsang CM, Pang PS, Zhang G, Chen
H and Lo KW: The biology of EBV infection in human epithelial
cells. Semin Cancer Biol. 22:137–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rickinson AB: Co-infections, inflammation
and oncogenesis: future directions for EBV research. Semin Cancer
Biol. 26:99–115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Imai S, Nishikawa J and Takada K:
Cell-to-cell contact as an efficient mode of Epstein-Barr virus
infection of diverse human epithelial cells. J Virol. 72:4371–4378.
1998.PubMed/NCBI
|
|
44
|
Hayashi K, Teramoto N, Akagi T, Sasaki Y
and Suzuki T: In situ detection of Epstein-Barr virus in the
gastric glands with intestinal metaplasia. Am J Gastroenterol.
91:14811996.PubMed/NCBI
|
|
45
|
Sugiura M, Imai S, Tokunaga M, et al:
Transcriptional analysis of Epstein-Barr virus gene expression in
EBV-positive gastric carcinoma: unique viral latency in the tumour
cells. Br J Cancer. 74:625–631. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Luo B, Wang Y, Wang XF, et al: Expression
of Epstein-Barr virus genes in EBV-associated gastric carcinomas.
World J Gastroenterol. 11:629–633. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Strong MJ, Xu G, Coco J, et al:
Differences in gastric carcinoma microenvironment stratify
according to EBV infection intensity: implications for possible
immune adjuvant therapy. PLoS Pathog. 9:e10033412013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tang W, Morgan DR, Meyers MO, et al:
Epstein-barr virus infected gastric adenocarcinoma expresses latent
and lytic viral transcripts and has a distinct human gene
expression profile. Infect Agent Cancer. 7:212012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shannon-Lowe C, Adland E, Bell AI,
Delecluse HJ, Rickinson AB and Rowe M: Features distinguishing
Epstein-Barr virus infections of epithelial cells and B cells:
viral genome expression, genome maintenance, and genome
amplification. J Virol. 83:7749–7760. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Iwakiri D and Takada K: Role of EBERs in
the pathogenesis of EBV infection. Adv Cancer Res. 107:119–136.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Iwakiri D, Eizuru Y, Tokunaga M and Takada
K: Autocrine growth of Epstein-Barr virus-positive gastric
carcinoma cells mediated by an Epstein-Barr virus-encoded small
RNA. Cancer Res. 63:7062–7067. 2003.PubMed/NCBI
|
|
52
|
Shinozaki A, Sakatani T, Ushiku T, et al:
Downregulation of microRNA-200 in EBV-associated gastric carcinoma.
Cancer Res. 70:4719–4727. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Banerjee AS, Pal AD and Banerjee S:
Epstein-Barr virus-encoded small non-coding RNAs induce cancer cell
chemoresistance and migration. Virology. 443:294–305. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Gruhne B, Sompallae R, Marescotti D,
Kamranvar SA, Gastaldello S and Masucci MG: The Epstein-Barr virus
nuclear antigen-1 promotes genomic instability via induction of
reactive oxygen species. Proc Natl Acad Sci USA. 106:2313–2318.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lu J, Murakami M, Verma SC, et al:
Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to
apoptosis in EBV-positive B-lymphoma cells through up-regulation of
survivin. Virology. 410:64–75. 2011. View Article : Google Scholar
|
|
56
|
Saridakis V, Sheng Y, Sarkari F, et al:
Structure of the p53 binding domain of HAUSP/USP7 bound to
Epstein-Barr nuclear antigen 1 implications for EBV-mediated
immortalization. Mol Cell. 18:25–36. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Cheng TC, Hsieh SS, Hsu WL, Chen YF, Ho HH
and Sheu LF: Expression of Epstein-Barr nuclear antigen 1 in
gastric carcinoma cells is associated with enhanced tumorigenicity
and reduced cisplatin sensitivity. Int J Oncol. 36:151–160.
2010.
|
|
58
|
Sivachandran N, Dawson CW, Young LS, Liu
FF, Middeldorp J and Frappier L: Contributions of the Epstein-Barr
virus EBNA1 protein to gastric carcinoma. J Virol. 86:60–68. 2012.
View Article : Google Scholar :
|
|
59
|
Yin Q and Flemington EK: siRNAs against
the Epstein Barr virus latency replication factor, EBNA1, inhibit
its function and growth of EBV-dependent tumor cells. Virology.
346:385–393. 2006. View Article : Google Scholar
|
|
60
|
Hong M, Murai Y, Kutsuna T, et al:
Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA
interference inhibits proliferation of EBV-positive Burkitt’s
lymphoma cells. J Cancer Res Clin Oncol. 132:1–8. 2006. View Article : Google Scholar
|
|
61
|
Ian MX, Lan SZ, Cheng ZF, Dan H and Qiong
LH: Suppression of EBNA1 expression inhibits growth of EBV-positive
NK/T cell lymphoma cells. Cancer Biol Ther. 7:1602–1606. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Fukuda M, Ikuta K, Yanagihara K, et al:
Effect of transforming growth factor-beta1 on the cell growth and
Epstein-Barr virus reactivation in EBV-infected epithelial cell
lines. Virology. 288:109–118. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Hino R, Uozaki H, Inoue Y, et al: Survival
advantage of EBV-associated gastric carcinoma: survivin
up-regulation by viral latent membrane protein 2A. Cancer Res.
68:1427–1435. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Liu X, Gao Y, Luo B and Zhao Y:
Construction and antiapoptosis activities of recombinant adenoviral
Expression vector carrying EBV latent membrane protein 2A.
Gastroenterol Res Pract. 2011:1828322011. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Pal AD, Basak NP, Banerjee AS and Banerjee
S: Epstein-Barr virus latent membrane protein-2A alters
mitochondrial dynamics promoting cellular migration mediated by
Notch signaling pathway. Carcinogenesis. 35:1592–1601. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Hino R, Uozaki H, Murakami N, et al:
Activation of DNA methyltransferase 1 by EBV latent membrane
protein 2A leads to promoter hypermethylation of PTEN gene in
gastric carcinoma. Cancer Res. 69:2766–2774. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhao J, Liang Q, Cheung KF, et al:
Genome-wide identification of Epstein-Barr virus-driven promoter
methylation profiles of human genes in gastric cancer cells.
Cancer. 119:304–312. 2013. View Article : Google Scholar
|
|
68
|
Al-Mozaini M, Bodelon G, Karstegl CE, Jin
B, Al-Ahdal M and Farrell PJ: Epstein-Barr virus BART gene
expression. J Gen Virol. 90:307–316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Thornburg NJ, Kusano S and Raab-Traub N:
Identification of Epstein-Barr virus RK-BARF0-interacting proteins
and characterization of expression pattern. J Virol.
78:12848–12856. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Hoebe EK, Le Large TY, Greijer AE and
Middeldorp JM: BamHI-A rightward frame 1, an Epstein-Barr
virus-encoded oncogene and immune modulator. Rev Med Virol.
23:367–383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
zur Hausen A, Brink AA, Craanen ME,
Middeldorp JM, Meijer CJ and van den Brule AJ: Unique transcription
pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric
adenocarcinomas: expression of the transforming BARF1 gene. Cancer
Res. 60:2745–2748. 2000.PubMed/NCBI
|
|
72
|
Wang Q, Tsao SW, Ooka T, et al:
Anti-apoptotic role of BARF1 in gastric cancer cells. Cancer Lett.
238:90–103. 2006. View Article : Google Scholar
|
|
73
|
Wiech T, Nikolopoulos E, Lassman S, et al:
Cyclin D1 expression is induced by viral BARF1 and is overexpressed
in EBV-associated gastric cancer. Virchows Arch. 452:621–627. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Chang MS, Kim DH, Roh JK, et al:
Epstein-Barr virus-encoded BARF1 promotes proliferation of gastric
carcinoma cells through regulation of NF-kappaB. J Virol.
87:10515–10523. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Kaneda A, Matsusaka K, Aburatani H and
Fukayama M: Epstein-Barr virus infection as an epigenetic driver of
tumorigenesis. Cancer Res. 72:3445–3450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Matsusaka K, Funata S, Fukayama M and
Kaneda A: DNA methylation in gastric cancer, related to
Helicobacter pylori and Epstein-Barr virus. World J Gastroenterol.
20:3916–3926. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Yau TO, Tang CM and Yu J: Epigenetic
dysregulation in Epstein-Barr virus-associated gastric carcinoma:
disease and treatments. World J Gastroenterol. 20:6448–6456. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Kusano M, Toyota M, Suzuki H, et al:
Genetic, epigenetic, and clinicopathologic features of gastric
carcinomas with the CpG island methylator phenotype and an
association with Epstein-Barr virus. Cancer. 106:1467–1479. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zong L and Seto Y: CpG island methylator
phenotype, helicobacter pylori, Epstein-Barr virus, and
microsatellite instability and prognosis in gastric cancer: a
systematic review and meta-analysis. PLoS One. 9:e860972014.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Okada T, Nakamura M, Nishikawa J, et al:
Identification of genes specifically methylated in Epstein-Barr
virus-associated gastric carcinomas. Cancer Sci. 104:1309–1314.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Saito M, Nishikawa J, Okada T, et al: Role
of DNA methylation in the development of Epstein-Barr
virus-associated gastric carcinoma. J Med Virol. 85:121–127. 2013.
View Article : Google Scholar
|
|
82
|
Chapel F, Fabiani B, Davi F, et al:
Epstein-Barr virus and gastric carcinoma in Western patients:
comparison of pathological parameters and p53 expression in
EBV-positive and negative tumours. Histopathology. 36:252–261.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Matsusaka K, Kaneda A, Nagae G, et al:
Classification of Epstein-Barr virus-positive gastric cancers by
definition of DNA methylation epigenotypes. Cancer Res.
71:7187–7197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
zur Hausen A, van Grieken NC, Meijer GA,
et al: Distinct chromosomal aberrations in Epstein-Barr
virus-carrying gastric carcinomas tested by comparative genomic
hybridization. Gastroenterology. 121:612–618. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Chan WY, Liu Y, Li CY, et al: Recurrent
genomic aberrations in gastric carcinomas associated with
Helicobacter pylori and Epstein-Barr virus. Diagn Mol Pathol.
11:127–134. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Chong JM, Fukayama M, Hayashi Y, et al:
Microsatellite instability in the progression of gastric carcinoma.
Cancer Res. 54:4595–4597. 1994.PubMed/NCBI
|
|
87
|
Lee J, van Hummelen P, Go C, et al:
High-throughput mutation profiling identifies frequent somatic
mutations in advanced gastric adenocarcinoma. PLoS One.
7:e388922012. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Sukawa Y, Yamamoto H, Nosho K, et al:
Alterations in the human epidermal growth factor receptor
2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.
World J Gastroenterol. 18:6577–6586. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
The Cancer Genome Atlas Research Network.
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Liang Q, Yao X, Tang S, et al: Integrative
identification of epstein-barr virus-associated mutations and
epigenetic alterations in gastric cancer. Gastroenterology.
147:1350–1362.e1354. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Wang K, Kan J, Yuen ST, et al: Exome
sequencing identifies frequent mutation of ARID1A in molecular
subtypes of gastric cancer. Nat Genet. 43:1219–1223. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Abe H, Maeda D, Hino R, et al: ARID1A
expression loss in gastric cancer: pathway-dependent roles with and
without Epstein-Barr virus infection and microsatellite
instability. Virchows Arch. 461:367–377. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Moritani S, Sugihara H, Kushima R and
Hattori T: Different roles of p53 between Epstein-Barr
virus-positive and -negative gastric carcinomas of matched
histology. Virchows Arch. 440:367–375. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Park HY, Kang SY, Kang GH, et al: EBV
infection and mismatch repair deficiency mediated by loss of hMLH1
expression contribute independently to the development of multiple
synchronous gastric carcinomas. J Surg Oncol. 106:777–782. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Dolan DE and Gupta S: PD-1 pathway
inhibitors: changing the landscape of cancer immunotherapy. Cancer
Control. 21:231–237. 2014.PubMed/NCBI
|
|
96
|
Naidoo J, Page DB and Wolchok JD: Immune
modulation for cancer therapy. Br J Cancer. 11:2214–2219. 2014.
View Article : Google Scholar
|
|
97
|
Marquitz AR, Mathur A, Shair KH and
Raab-Traub N: Infection of Epstein-Barr virus in a gastric
carcinoma cell line induces anchorage independence and global
changes in gene expression. Proc Natl Acad Sci USA. 109:9593–9598.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Kim SY, Park C, Kim HJ, et al:
Deregulation of immune response genes in patients with Epstein-Barr
virus-associated gastric cancer and outcomes. Gastroenterology.
148:137–147.e139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Chen BJ, Chapuy B, Ouyang J, et al: PD-L1
expression is characteristic of a subset of aggressive B-cell
lymphomas and virus-associated malignancies. Clin Cancer Res.
19:3462–3473. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Green MR, Rodig S, Juszczynski P, et al:
Constitutive AP-1 activity and EBV infection induce PD-L1 in
Hodgkin lymphomas and posttransplant lymphoproliferative disorders:
implications for targeted therapy. Clin Cancer Res. 18:1611–1618.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Kim do N and Lee SK: Biogenesis of
Epstein-Barr virus microRNAs. Mol Cell Biochem. 365:203–210. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Pfeffer S, Zavolan M, Grasser FA, et al:
Identification of virus-encoded microRNAs. Science. 304:734–736.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Barth S, Meister G and Grasser FA:
EBV-encoded miRNAs. Biochim Biophys Acta. 1809:631–640. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Chan JY, Gao W, Ho WK, Wei WI and Wong TS:
Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in
undifferentiated nasopharyngeal carcinoma. Anticancer Res.
32:3201–3210. 2012.PubMed/NCBI
|
|
105
|
Chen SJ, Chen GH, Chen YH, et al:
Characterization of Epstein-Barr virus miRNAome in nasopharyngeal
carcinoma by deep sequencing. PLoS One. 5:e127452010. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Choi H, Lee H, Kim SR, Gho YS and Lee SK:
Epstein-Barr virus-encoded microRNA BART15-3p promotes cell
apoptosis partially by targeting BRUCE. J Virol. 87:8135–8144.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Choy EY, Siu KL, Kok KH, et al: An
Epstein-Barr virus-encoded microRNA targets PUMA to promote host
cell survival. J Exp Med. 205:2551–2560. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Cosmopoulos K, Pegtel M, Hawkins J, et al:
Comprehensive profiling of Epstein-Barr virus microRNAs in
nasopharyngeal carcinoma. J Virol. 83:2357–2367. 2009. View Article : Google Scholar :
|
|
109
|
Gourzones C, Gelin A, Bombik I, et al:
Extra-cellular release and blood diffusion of BART viral micro-RNAs
produced by EBV-infected nasopharyngeal carcinoma cells. Virol J.
7:2712010. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Gourzones C, Ferrand FR, Amiel C, et al:
Consistent high concentration of the viral microRNA BART17 in
plasma samples from nasopharyngeal carcinoma patients - evidence of
non-exosomal transport. Virol J. 10:1192013. View Article : Google Scholar :
|
|
111
|
Imig J, Motsch N, Zhu JY, et al: microRNA
profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic
Acids Res. 39:1880–1893. 2011. View Article : Google Scholar :
|
|
112
|
Lung RW, Tong JH and To KF: Emerging roles
of small Epstein-Barr virus derived non-coding RNAs in epithelial
malignancy. Int J Mol Sci. 14:17378–17409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Marquitz AR, Mathur A, Nam CS and
Raab-Traub N: The Epstein-Barr Virus BART microRNAs target the
pro-apoptotic protein Bim. Virology. 412:392–400. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Motsch N, Alles J, Imig J, et al: MicroRNA
profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by
deep sequencing. PLoS One. 7:e421932012. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Nourse JP, Crooks P, Keane C, et al:
Expression profiling of Epstein-Barr virus-encoded microRNAs from
paraffin-embedded formalin-fixed primary Epstein-Barr
virus-positive B-cell lymphoma samples. J Virol Methods. 184:46–54.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Riley KJ, Rabinowitz GS, Yario TA, Luna
JM, Darnell RB and Steitz JA: EBV and human microRNAs co-target
oncogenic and apoptotic viral and human genes during latency. EMBO
J. 31:2207–2221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Vereide DT, Seto E, Chiu YF, et al:
Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene.
33:1258–1264. 2014. View Article : Google Scholar
|
|
118
|
Wong AM, Kong KL, Tsang JW, Kwong DL and
Guan XY: Profiling of Epstein-Barr virus-encoded microRNAs in
nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
Cancer. 118:698–710. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Xia T, O’Hara A, Araujo I, et al: EBV
microRNAs in primary lymphomas and targeting of CXCL-11 by
ebv-mir-BHRF1-3. Cancer Res. 68:1436–1442. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Zhu JY, Pfuhl T, Motsch N, et al:
Identification of novel Epstein-Barr virus microRNA genes from
nasopharyngeal carcinomas. J Virol. 83:3333–3341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Qiu J and Thorley-Lawson DA: EBV microRNA
BART 18-5p targets MAP3K2 to facilitate persistence in vivo by
inhibiting viral replication in B cells. Proc Natl Acad Sci USA.
111:11157–11162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Kim do N, Chae HS, Oh ST, et al:
Expression of viral microRNAs in Epstein-Barr virus-associated
gastric carcinoma. J Virol. 81:1033–1036. 2007. View Article : Google Scholar :
|
|
123
|
Marquitz AR, Mathur A, Chugh PE, Dittmer
DP and Raab-Traub N: Expression profile of microRNAs in
Epstein-Barr virus-infected AGS gastric carcinoma cells. J Virol.
88:1389–1393. 2014. View Article : Google Scholar :
|
|
124
|
Kim do N, Seo MK, Choi H, et al:
Characterization of naturally Epstein-Barr virus-infected gastric
carcinoma cell line YCCEL1. J Gen Virol. 94:497–506. 2013.
View Article : Google Scholar
|
|
125
|
Qiu J, Cosmopoulos K, Pegtel M, et al: A
novel persistence associated EBV miRNA expression profile is
disrupted in neoplasia. PLoS Pathog. 7:e10021932011. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Skalsky RL, Corcoran DL, Gottwein E, et
al: The viral and cellular microRNA targetome in lymphoblastoid
cell lines. PLoS Pathog. 8:e10024842012. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Lo AK, To KF, Lo KW, et al: Modulation of
LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad
Sci USA. 104:16164–16169. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Barth S, Pfuhl T, Mamiani A, et al:
Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the
viral DNA polymerase BALF5. Nucleic Acids Res. 36:666–675. 2008.
View Article : Google Scholar :
|
|
129
|
Dolken L, Malterer G, Erhard F, et al:
Systematic analysis of viral and cellular microRNA targets in cells
latently infected with human gamma-herpesviruses by RISC
immunoprecipitation assay. Cell Host Microbe. 7:324–334. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Iizasa H, Wulff BE, Alla NR, et al:
Editing of Epstein-Barr virus-encoded BART6 microRNAs controls
their dicer targeting and consequently affects viral latency. J
Biol Chem. 285:33358–33370. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Ambrosio MR, Navari M, Di Lisio L, et al:
The Epstein Barr-encoded BART-6-3p microRNA affects regulation of
cell growth and immuno response in Burkitt lymphoma. Infect Agent
Cancer. 9:122014. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Ramakrishnan R, Donahue H, Garcia D, et
al: Epstein-Barr virus BART9 miRNA modulates LMP1 levels and
affects growth rate of nasal NK T cell lymphomas. PLoS One.
6:e272712011. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Hsu CY, Yi YH, Chang KP, Chang YS, Chen SJ
and Chen HC: The Epstein-Barr virus-encoded microRNA miR-BART9
promotes tumor metastasis by targeting E-cadherin in nasopharyngeal
carcinoma. PLoS Pathog. 10:e10039742014. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Ross N, Gandhi MK and Nourse JP: The
Epstein-Barr virus microRNA BART11-5p targets the early B-cell
transcription factor EBF1. Am J Blood Res. 3:210–224.
2013.PubMed/NCBI
|
|
135
|
Haneklaus M, Gerlic M, Kurowska-Stolarska
M, et al: Cutting edge: miR-223 and EBV miR-BART15 regulate the
NLRP3 inflammasome and IL-1beta production. J Immunol.
189:3795–3799. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Jung YJ, Choi H, Kim H and Lee SK:
MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by
directly targeting BZLF1 and BRLF1. J Virol. 88:9027–9037. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Lin TC, Liu TY, Hsu SM and Lin CW:
Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation
with secondary suppression of p53 in invasive nasal NK/T-cell
lymphoma. Am J Pathol. 182:1865–1875. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Lung RW, Tong JH, Sung YM, et al:
Modulation of LMP2A expression by a newly identified Epstein-Barr
virus-encoded microRNA miR-BART22. Neoplasia. 11:1174–1184.
2009.PubMed/NCBI
|
